title: HMG CoA reduction in patients with average cholesterol concentrations.
authors.affiliation: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ebraunwald@partners.org
authors.forename: Eugene
authors.initials: E
authors.lastname: Braunwald
authors.forename: Frank M
authors.initials: FM
authors.lastname: Sacks
authors.forename: Marc A
authors.initials: MA
authors.lastname: Pfeffer
authors.forename: Paul M
authors.initials: PM
authors.lastname: Ridker
mesh_terms: D002784:Cholesterol / Q000097:blood*; D003324:Coronary Artery Disease / Q000097:blood / Q000401:mortality / Q000517:prevention & control; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000097:blood*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000097:blood / Q000517:prevention & control; D017035:Pravastatin / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases; D017035:Pravastatin